Calendar NRx Pharmaceuticals, Inc.

Equities

BRPA

US6294442099

Market Closed - Nasdaq 21:30:01 03/05/2024 BST 5-day change 1st Jan Change
2.1 USD +1.94% Intraday chart for NRx Pharmaceuticals, Inc. -40.68% -54.35%

Chart calendar NRx Pharmaceuticals, Inc.

e31facb0a8cac77750f9de04f261375._hg-CBf-H3Rr8dqLn-rioLb-YMREKI1cFqhVOIAsMfU.jlVxYGeIczcbmu3n3Juw8IGTUaw9TfsvQco8XNBmfrO9fltOZ7NMEB25uQ~cb9638538e4c332610e62816764b85ce

Upcoming events on NRx Pharmaceuticals, Inc.

13/05/2024 Q1 2024 Earnings Release (Projected)
14/05/2024 EF Hutton Investor Conference
11/08/2024 Q2 2024 Earnings Release (Projected)
10/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)

Past events on NRx Pharmaceuticals, Inc.

01/04/2024 13:30 Q4 2023 Earnings Call
01/04/2024 13:28 Q4 2023 Earnings Release
25/03/2024 13:40 Ketamine Conference
20/03/2024 Extraordinary Shareholders Meeting
26/02/2024 19:30 BIO CEO & Investor Conference
08/01/2024 16:00 LifeSci Partners Corporate Access Event
06/01/2024 Sachs Neuroscience Innovation Forum
19/12/2023 16:00 Annual General Meeting
04/12/2023 21:30 Noble Capital Markets Emerging Growth Equity Conference
14/11/2023 21:30 Q3 2023 Earnings Call
13/11/2023 23:39 Q3 2023 Earnings Release
12/10/2023 21:00 Dawson James Small Cap Growth Conference
21/09/2023 14:15 Sidoti Small Cap Conference
12/09/2023 22:00 H.C. Wainwright Global Investment Conference
14/08/2023 21:30 Q2 2023 Earnings Call
14/08/2023 21:09 Q2 2023 Earnings Release
26/06/2023 14:00 H.C. Wainwright Neuropsychiatry Virtual Conference
05/06/2023 13:30 Business Update Call
16/05/2023 13:30 Q1 2023 Earnings Call
16/05/2023 11:47 Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-44,4
-43,8
-1.36%
-27,8
-29,6
5.8%

-32,0

Earnings before Tax (EBT)
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-

0,00

Net income
Million USD
Released
Forecast
Spread
-93,1


0,00
0,00
-
0,00
0,00
-

0,00

EPS
USD
Released
Forecast
Spread
-74,4


0,00
0,00
-
0,00
0,00
-

0,00

Announcement Date31/03/2230/03/2329/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-9,60
-6,90
-39.13%
-9,14
-9,60
4.78%
-9,95
-9,40
-5.85%
-9,44
-9,00
-4.83%
-8,19
-9,65
15.15%
-5,81
-9,00
35.47%
-4,41
-6,15
28.36%

-6,50


-6,50


-6,50


-6,50

Announcement Date15/08/2214/11/2230/03/2315/05/2314/08/2313/11/2329/03/24----

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BRPA Stock
  4. Calendar NRx Pharmaceuticals, Inc.